Compare Oscar Health Inc (OSCR) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oscar Health Inc vs Tempus AI — how do they compare? Oscar Health Inc trades at $33.05 (market cap $10.16B), while Tempus AI trades at $70 (market cap $12.77B). The key difference: Tempus AI is the larger of the two by market cap, and Oscar Health Inc is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and Tempus AI for 22 Days on average.
| OSCR | TEM | |
|---|---|---|
Market Cap | $10.16B | $12.77B |
Volume | 5,418,697 | 8,980,490 |
Sector | Health | Broad Market / Factor |
52-Week High | $33.81 | $99.28 |
52-Week Low | $10.85 | $41.55 |
Typical Hold Time | 15 Days | 22 Days |
Enterprise Value | $6.51B | $13.40B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Oscar Health (OSCR) trades at $32.91, up 1.76% with strong technical momentum and bullish moving average signals. The company shows impressive revenue growth from $11.7B in 2025 to $15.3B in 2026, with profitability turning positive at $551M net income. Recent earnings beats and raised guidance have driven positive sentiment, though the stock faces challenges from rising medical costs and competitive pressures in the ACA market.
The outlook remains constructive with analyst consensus at $34.00 and strong institutional interest, though investors should monitor execution risks and medical cost trends. The combination of market share gains, margin expansion potential, and bullish technical setup supports further upside if the company can maintain its growth trajectory.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
